Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
Clinical trial NCT02885168 · COMPLETED
Trial details
- NCT number
- NCT02885168
- Sponsor
- Central Hospital, Nancy, France
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.